Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”
Sens. Elizabeth Warren (Mass.) and Amy Klobuchar (Minn.) and Reps. Katie Porter (Calif.) and Jan Schakowsky (Ill.) organized the March 1 letter to PhRMA President and CEO Stephen Ubl. Sens. Tammy Baldwin (Wis.), Maggie Hassan (N.H.), Bernard Sanders (I-Vt.), Tina Smith (Minn.), Sheldon Whitehouse (R.I.), and Ron Wyden (Ore.) and Reps. Peter DeFazio (Ore.), Peter Welch (Vt.), and Susan Wild (Pa.) signed it.
Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
